PriceTargets.com logo

Milestone Scientific - MLSS Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $1.25
  • Forecasted Upside: 35.14%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
$0.93 As of 12/20/2024 06:31 PM ET
▲ +0.1279 (16.05%)

This chart shows the closing price for MLSS by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Milestone Scientific Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MLSS and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MLSS

Analyst Price Target is $1.25
▲ +35.14% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for Milestone Scientific in the last 3 months. The average price target is $1.25, with a high forecast of $1.25 and a low forecast of $1.25. The average price target represents a 35.14% upside from the last price of $0.93.

This chart shows the closing price for MLSS for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 contributing investment analysts is to buy stock in Milestone Scientific.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/30/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/28/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/27/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/24/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/22/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/21/2024
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/21/2024

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
11/20/2024BenchmarkReiterated RatingSpeculative Buy ➝ Speculative Buy$1.25 ➝ $1.25
10/10/2024BenchmarkInitiated CoverageSpeculative Buy$1.25
4/4/2022Maxim GroupLower Target$6.00 ➝ $4.00
9/16/2020Northland SecuritiesInitiated CoverageMarket Perform
8/17/2020Maxim GroupReiterated RatingBuy$4.00
6/23/2020Maxim GroupReiterated RatingBuy$4.00
5/19/2020Maxim GroupReiterated RatingBuy$3.00
4/1/2020Maxim GroupReiterated RatingBuy$3.00
(Data available from 12/21/2019 forward)

News Sentiment Rating

0.41 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/25/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/24/2024
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
7/24/2024
  • 3 very positive mentions
  • 11 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
8/23/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2024
  • 0 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2024
  • 3 very positive mentions
  • 16 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2024
  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2024

Current Sentiment

  • 1 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Milestone Scientific logo
Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.
Read More

Today's Range

Now: $0.93
Low: $0.80
High: $0.93

50 Day Range

MA: $0.81
Low: $0.62
High: $1.02

52 Week Range

Now: $0.93
Low: $0.52
High: $1.10

Volume

419,214 shs

Average Volume

117,733 shs

Market Capitalization

$72.05 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.1

Frequently Asked Questions

What sell-side analysts currently cover shares of Milestone Scientific?

The following equities research analysts have issued stock ratings on Milestone Scientific in the last year: Benchmark Co., and StockNews.com.
View the latest analyst ratings for MLSS.

What is the current price target for Milestone Scientific?

0 Wall Street analysts have set twelve-month price targets for Milestone Scientific in the last year. Their average twelve-month price target is $1.25, suggesting a possible upside of 35.1%. Benchmark Co. has the highest price target set, predicting MLSS will reach $1.25 in the next twelve months. Benchmark Co. has the lowest price target set, forecasting a price of $1.25 for Milestone Scientific in the next year.
View the latest price targets for MLSS.

What is the current consensus analyst rating for Milestone Scientific?

Milestone Scientific currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe MLSS will outperform the market and that investors should add to their positions of Milestone Scientific.
View the latest ratings for MLSS.

What other companies compete with Milestone Scientific?

Other companies that are similar to Milestone Scientific include Pulmonx, Electromed, Perspective Therapeutics, Alpha Tau Medical and Profound Medical. Learn More about companies similar to Milestone Scientific.

How do I contact Milestone Scientific's investor relations team?

Milestone Scientific's physical mailing address is 425 Eagle Rock Avenue Suite 403, Roseland NJ, 07068. The company's listed phone number is (973) 535-2717 and its investor relations email address is [email protected]. The official website for Milestone Scientific is www.milestonescientific.com. Learn More about contacing Milestone Scientific investor relations.